Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 29527 | 184 | 44.4 | 68% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
| 497 | 3 | CANNABINOID//ANANDAMIDE//ENDOCANNABINOIDS | 22707 |
| 535 | 2 | CANNABINOID//ENDOCANNABINOIDS//ANANDAMIDE | 14838 |
| 29527 | 1 | 2 ARACHIDONOYLGLYCEROL ANANDAMIDE//ANANDAMIDE TRANSPORT INHIBITORS//ANTIGLAUCOMA ACTIVITY | 184 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | 2 ARACHIDONOYLGLYCEROL ANANDAMIDE | authKW | 165954 | 1% | 100% | 1 |
| 2 | ANANDAMIDE TRANSPORT INHIBITORS | authKW | 165954 | 1% | 100% | 1 |
| 3 | ANTIGLAUCOMA ACTIVITY | authKW | 165954 | 1% | 100% | 1 |
| 4 | ANTIGLAUCOMATOUS DRUGS | authKW | 165954 | 1% | 100% | 1 |
| 5 | C MONDIO FDN | address | 165954 | 1% | 100% | 1 |
| 6 | CANASOL | authKW | 165954 | 1% | 100% | 1 |
| 7 | CANNABINOID RETINA | authKW | 165954 | 1% | 100% | 1 |
| 8 | CB1 CB2 RECEPTOR AGONIST | authKW | 165954 | 1% | 100% | 1 |
| 9 | CID16020046 | authKW | 165954 | 1% | 100% | 1 |
| 10 | CORNEAL MIGRATION | authKW | 165954 | 1% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Ophthalmology | 6978 | 52% | 0% | 96 |
| 2 | Pharmacology & Pharmacy | 479 | 31% | 0% | 57 |
| 3 | Neurosciences | 256 | 23% | 0% | 43 |
| 4 | Chemistry, Medicinal | 36 | 5% | 0% | 9 |
| 5 | Integrative & Complementary Medicine | 11 | 1% | 0% | 2 |
| 6 | Zoology | 9 | 3% | 0% | 6 |
| 7 | Substance Abuse | 6 | 1% | 0% | 2 |
| 8 | Toxicology | 4 | 2% | 0% | 4 |
| 9 | Anatomy & Morphology | 1 | 1% | 0% | 1 |
| 10 | Cell Biology | 1 | 3% | 0% | 6 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | C MONDIO FDN | 165954 | 1% | 100% | 1 |
| 2 | FTMS | 165954 | 1% | 100% | 1 |
| 3 | GLAUCOMA PHARMACOL | 165954 | 1% | 100% | 1 |
| 4 | INVEST CLIN CIC | 165954 | 1% | 100% | 1 |
| 5 | MONDINO TOR VERGATA EXPT NEUROPHARMA AB N | 165954 | 1% | 100% | 1 |
| 6 | NEUROPHARMCOL | 165954 | 1% | 100% | 1 |
| 7 | OPHTHALMOL ASL 8 | 165954 | 1% | 100% | 1 |
| 8 | PHARM SCI DRUG | 165954 | 1% | 100% | 1 |
| 9 | PHARMACOL PRECLIN TOXICOL NAT PROD | 165954 | 1% | 100% | 1 |
| 10 | PLASTICITE VISUELLE | 165954 | 1% | 100% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | CURRENT EYE RESEARCH | 9601 | 9% | 0% | 17 |
| 2 | NEURAL PLASTICITY | 7292 | 3% | 1% | 6 |
| 3 | VISUAL NEUROSCIENCE | 6191 | 5% | 0% | 9 |
| 4 | JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS | 3658 | 3% | 0% | 6 |
| 5 | JOURNAL OF TOXICOLOGY-CUTANEOUS AND OCULAR TOXICOLOGY | 3145 | 2% | 1% | 3 |
| 6 | EXPERIMENTAL EYE RESEARCH | 2529 | 5% | 0% | 10 |
| 7 | INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2472 | 9% | 0% | 17 |
| 8 | OPHTHALMIC RESEARCH | 1961 | 3% | 0% | 5 |
| 9 | MOLECULAR VISION | 1810 | 3% | 0% | 6 |
| 10 | PROGRESS IN NEURO-PSYCHOPHARMACOLOGY | 1192 | 1% | 1% | 1 |
Author Key Words |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | 2 ARACHIDONOYLGLYCEROL ANANDAMIDE | 165954 | 1% | 100% | 1 | Search 2+ARACHIDONOYLGLYCEROL+ANANDAMIDE | Search 2+ARACHIDONOYLGLYCEROL+ANANDAMIDE |
| 2 | ANANDAMIDE TRANSPORT INHIBITORS | 165954 | 1% | 100% | 1 | Search ANANDAMIDE+TRANSPORT+INHIBITORS | Search ANANDAMIDE+TRANSPORT+INHIBITORS |
| 3 | ANTIGLAUCOMA ACTIVITY | 165954 | 1% | 100% | 1 | Search ANTIGLAUCOMA+ACTIVITY | Search ANTIGLAUCOMA+ACTIVITY |
| 4 | ANTIGLAUCOMATOUS DRUGS | 165954 | 1% | 100% | 1 | Search ANTIGLAUCOMATOUS+DRUGS | Search ANTIGLAUCOMATOUS+DRUGS |
| 5 | CANASOL | 165954 | 1% | 100% | 1 | Search CANASOL | Search CANASOL |
| 6 | CANNABINOID RETINA | 165954 | 1% | 100% | 1 | Search CANNABINOID+RETINA | Search CANNABINOID+RETINA |
| 7 | CB1 CB2 RECEPTOR AGONIST | 165954 | 1% | 100% | 1 | Search CB1+CB2+RECEPTOR+AGONIST | Search CB1+CB2+RECEPTOR+AGONIST |
| 8 | CID16020046 | 165954 | 1% | 100% | 1 | Search CID16020046 | Search CID16020046 |
| 9 | CORNEAL MIGRATION | 165954 | 1% | 100% | 1 | Search CORNEAL+MIGRATION | Search CORNEAL+MIGRATION |
| 10 | DRIVING IMPAIRMENTS | 165954 | 1% | 100% | 1 | Search DRIVING+IMPAIRMENTS | Search DRIVING+IMPAIRMENTS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | BOUCHARD, JF , CASANOVA, C , CECYRE, B , REDMOND, WJ , (2016) EXPRESSION AND FUNCTION OF THE ENDOCANNABINOID SYSTEM IN THE RETINA AND THE VISUAL BRAIN.NEURAL PLASTICITY. VOL. . ISSUE . P. - | 45 | 42% | 3 |
| 2 | CAIRNS, EA , BALDRIDGE, WH , KELLY, MEM , (2016) THE ENDOCANNABINOID SYSTEM AS A THERAPEUTIC TARGET IN GLAUCOMA.NEURAL PLASTICITY. VOL. . ISSUE . P. - | 40 | 44% | 3 |
| 3 | SCHWITZER, T , SCHWAN, R , ANGIOI-DUPREZ, K , GIERSCH, A , LAPREVOTE, V , (2016) THE ENDOCANNABINOID SYSTEM IN THE RETINA: FROM PHYSIOLOGY TO PRACTICAL AND THERAPEUTIC APPLICATIONS.NEURAL PLASTICITY. VOL. . ISSUE . P. - | 43 | 43% | 1 |
| 4 | SZCZESNIAK, AM , MAOR, Y , ROBERTSON, H , HUNG, O , KELLY, MEM , (2011) NONPSYCHOTROPIC CANNABINOIDS, ABNORMAL CANNABIDIOL AND CANABIGEROL-DIMETHYL HEPTYL, ACT AT NOVEL CANNABINOID RECEPTORS TO REDUCE INTRAOCULAR PRESSURE.JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS. VOL. 27. ISSUE 5. P. 427 -435 | 35 | 53% | 4 |
| 5 | KOKONA, D , GEORGIOU, PC , KOUNENIDAKIS, M , KIAGIADAKI, F , THERMOS, K , (2016) ENDOGENOUS AND SYNTHETIC CANNABINOIDS AS THERAPEUTICS IN RETINAL DISEASE.NEURAL PLASTICITY. VOL. . ISSUE . P. - | 33 | 34% | 1 |
| 6 | CHIEN, FY , WANG, RF , MITTAG, TW , PODOS, SM , (2003) EFFECT OF WIN 55212-2, A CANNABINOID RECEPTOR AGONIST, ON AQUEOUS HUMOR DYNAMICS IN MONKEYS.ARCHIVES OF OPHTHALMOLOGY. VOL. 121. ISSUE 1. P. 87-90 | 17 | 85% | 33 |
| 7 | SCHWITZER, T , SCHWAN, R , ANGIOI-DUPREZ, K , INGSTER-MOATI, I , LALANNE, L , GIERSCH, A , LAPREVOTE, V , (2015) THE CANNABINOID SYSTEM AND VISUAL PROCESSING: A REVIEW ON EXPERIMENTAL FINDINGS AND CLINICAL PRESUMPTIONS.EUROPEAN NEUROPSYCHOPHARMACOLOGY. VOL. 25. ISSUE 1. P. 100 -112 | 34 | 25% | 3 |
| 8 | CHEN, J , MATIAS, I , DINH, T , LU, T , VENEZIA, S , NIEVES, A , WOODWARD, DF , DI MARZO, V , (2005) FINDING OF ENDOCANNABINOIDS IN HUMAN EYE TISSUES: IMPLICATIONS FOR GLAUCOMA.BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. VOL. 330. ISSUE 4. P. 1062-1067 | 21 | 49% | 50 |
| 9 | TOGURI, JT , CALDWELL, M , KELLY, MEM , (2016) TURNING DOWN THE THERMOSTAT: MODULATING THE ENDOCANNABINOID SYSTEM IN OCULAR INFLAMMATION AND PAIN.FRONTIERS IN PHARMACOLOGY. VOL. 7. ISSUE . P. - | 25 | 34% | 0 |
| 10 | JARVINEN, T , PATE, DW , LAINE, K , (2002) CANNABINOIDS IN THE TREATMENT OF GLAUCOMA.PHARMACOLOGY & THERAPEUTICS. VOL. 95. ISSUE 2. P. 203 -220 | 40 | 27% | 79 |
Classes with closest relation at Level 1 |